96 related articles for article (PubMed ID: 15484343)
1. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.
Stadler RF; Gregorcyk SG; Euhus DM; Place RJ; Huber PJ; Simmang CL
Dis Colon Rectum; 2004 Aug; 47(8):1305-9. PubMed ID: 15484343
[TBL] [Abstract][Full Text] [Related]
2. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence.
Crum-Cianflone NF; Hullsiek KH; Marconi VC; Ganesan A; Weintrob A; Barthel RV; Agan BK;
AIDS; 2010 Feb; 24(4):535-43. PubMed ID: 19926961
[TBL] [Abstract][Full Text] [Related]
3. Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients.
Susko M; Wang CJ; Lazar AA; Kim S; Laffan A; Feng M; Ko A; Venook AP; Atreya CE; Van Loon K; Anwar M
Oncologist; 2020 Sep; 25(9):772-779. PubMed ID: 32390297
[TBL] [Abstract][Full Text] [Related]
4. Five year experience of the treatment of squamous cell carcinoma of the anus.
Leo CA; Santorelli C; Hodgkinson JD; Bidovaneta O; Baldelli F; Cantarella F; Cavazzoni E
G Chir; 2017; 38(4):176-180. PubMed ID: 29182899
[TBL] [Abstract][Full Text] [Related]
5. Anal cancer: a 20-year retrospective study from Australia.
Wong J; Allwright M; Hruby G; Roberts JM; Carr A; Jin F; Gett R; Meagher AP; Hillman R
ANZ J Surg; 2023 Nov; 93(11):2697-2705. PubMed ID: 37475502
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Models of Anal Cancer Combined-Modality Therapy.
Johnson HR; Gunder LC; Gillette A; Sleiman H; Rademacher BL; Meske LM; Culberson WS; Micka JA; Favreau P; Yao E; Matkowskyj KA; Skala MC; Carchman EH
J Surg Res; 2024 Feb; 294():82-92. PubMed ID: 37864962
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers in anal cancer: from biological understanding to stratified treatment.
Jones CM; Goh V; Sebag-Montefiore D; Gilbert DC
Br J Cancer; 2017 Jan; 116(2):156-162. PubMed ID: 27923035
[TBL] [Abstract][Full Text] [Related]
8. Differences in the Course of CD4 and CD8 Cells After Chemoradiotherapy in People Living with HIV with Anal Cancer.
Schuettfort G; Röther C; Berger A; Fokas E; Fraunholz I; Groh A; Haberl A; Khaykin P; Martin D; Rödel C; Vehreschild M; Stephan C
AIDS Res Hum Retroviruses; 2024 Apr; 40(4):198-203. PubMed ID: 37756364
[TBL] [Abstract][Full Text] [Related]
9. Beyond squamous cell carcinoma: MRI appearance of uncommon anal neoplasms and mimickers.
El Homsi M; Golia Pernicka JS; Lall C; Nougaret S; Paspulati RM; Pickhardt PJ; Sheedy SP; Petkovska I
Abdom Radiol (NY); 2023 Sep; 48(9):2898-2912. PubMed ID: 37027015
[TBL] [Abstract][Full Text] [Related]
10. SEOM clinical guidelines for the treatment of anal cancer.
Maurel J; Fernández-Martos C; Feliu J; Isla D
Clin Transl Oncol; 2011 Aug; 13(8):525-7. PubMed ID: 21821485
[TBL] [Abstract][Full Text] [Related]
11. Understanding the molecular biology of anal squamous cell carcinoma.
Samuel RJ; Gilbert DC
Int J Cancer; 2024 Feb; 154(3):410-411. PubMed ID: 37908043
[No Abstract] [Full Text] [Related]
12. Rational treatment options for T1/2N0M0 squamous cell carcinoma of the anal canal: a population-based study combined with external validation.
Shao X; Zhang Q; Huo Y; Lu C
Oncologist; 2024 Apr; ():. PubMed ID: 38688457
[TBL] [Abstract][Full Text] [Related]
13. IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma.
De Felice F; Franco P
Med Oncol; 2023 Nov; 40(12):356. PubMed ID: 37962690
[TBL] [Abstract][Full Text] [Related]
14. Cancer of the anal canal, a reality in the Colombian coffee region. Clinical-epidemiological review 2000-2019.
Mejía CRV; Jaramillo MV; Jaramillo PV
Ecancermedicalscience; 2021; 15():1181. PubMed ID: 33777174
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for squamous cell cancer of the anal canal.
Das P; Crane CH; Eng C; Ajani JA
Gastrointest Cancer Res; 2008 Jan; 2(1):10-4. PubMed ID: 19259318
[TBL] [Abstract][Full Text] [Related]
16. Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infection.
Kamei S; Kaneto H; Hashiramoto M; Hisano Y; Tanabe A; Shimoda M; Tawaramoto K; Anno T; Mune T; Matsuki M; Kaku K
J Diabetes Investig; 2015 May; 6(3):367-8. PubMed ID: 25969724
[No Abstract] [Full Text] [Related]
17. Correction to: Encephalitis in HIV‑infected adults in the antiretroviral therapy era.
Reimer-McAtee M; Ramirez D; McAtee CL; Granillo A; Hasbun R
J Neurol; 2023 Sep; 270(9):4582. PubMed ID: 37272964
[No Abstract] [Full Text] [Related]
18. HIV-Associated Anal Cancer.
Khandwala P; Singhal S; Desai D; Parsi M; Potdar R
Cureus; 2021 May; 13(5):e14834. PubMed ID: 34104584
[TBL] [Abstract][Full Text] [Related]
19. Difference in toxicity between HIV-positive and HIV-negative patients with squamous-cell cancer of the anal canal treated with concomitant radio-chemotherapy.
Casadiego-Peña C; Torres-Minacapilli M; Najera M; Ferrer P; Chajon E; Marsiglia H
J Gastrointest Oncol; 2020 Feb; 11(1):23-35. PubMed ID: 32175102
[TBL] [Abstract][Full Text] [Related]
20. Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.
Klausner G; Blais E; Jumeau R; Biau J; de Meric de Bellefon M; Ozsahin M; Zilli T; Miralbell R; Thariat J; Troussier I
Med Oncol; 2018 Aug; 35(10):134. PubMed ID: 30128811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
